Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Phosphorylation Site Page:
Thr1765 - ITGB4 (human)

Site Information
sEyssItttHTSAtE   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: ITGB4 (rat): (S1749), ITGB4 iso2 (mouse): (S1696), ITGB4 iso2 (human): (T1695), ITGB4 iso3 (human): (T1748), ITGB4 (mouse): (S1761), ITGB4 iso3 (mouse): (S1749)
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 3652622

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2)
Disease tissue studied: breast cancer (2), leukemia (1), chronic myelogenous leukemia (1)
Relevant cell line - cell type - tissue: K562 (erythroid) (1), MCF10A1 (epithelial) (2), MCF10AT1K (epithelial) (2), MCF10CA1a (epithelial) (2), MCF10CA1h (epithelial) (2)



Possemato A (2010) CST Curation Set: 9956; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info


Chen Y, et al. (2007) Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics 6, 2072-87
17855441   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.